US monetary policy influence on an increasingly globalised economy

From Quantitative Easing to Tightening Policies On Tuesday 16th December 2008, following the recession, the Federal Reserve lowered its benchmark interest rate to a range of 0 – 0.25%. The central bank also implemented the Quantitative Easing, which consists in purchasing US Treasuries and mortgage-backed securities to increase liquidity and stimulate the economy with newContinue reading “US monetary policy influence on an increasingly globalised economy”

Small investment bank boutiques cash in on mega M&A deals

(On the right side is Simon Warshaw and on the left side is Michael Zaoui)   While it’s normal that big name players take mega deals in M&A market, small investment bank boutiques in London have shared a bigger slice of the pie than ever before, and, many times, some of them are beating bigContinue reading “Small investment bank boutiques cash in on mega M&A deals”

US-China Trade War Effect on the EU

Back in March we introduced and briefly discussed Trump’s intention to impose tariffs on steel and aluminum goods. In less than a year those trade disputes escalated in a trade war, impacting not only the two involved countries but also other trading partners, including the EU. The disaffection versus international institutions has been driven byContinue reading “US-China Trade War Effect on the EU”

The Race has started for European PE firms to join the $100bn Club!

By Ascanio Rossini The race to become Europe’s first $100bn private-equity firm is accelerating as the recent fundraising boom shows. Europe’s largest investment firms, including Ardian, Partners Group and CVC Capital Partners, are closing in on $100bn in AuM after raising some of their largest-ever funds in recent years and launching new investment strategies inContinue reading “The Race has started for European PE firms to join the $100bn Club!”

ALL TIME CLASSIC! KKR’s first leveraged buyout battle ($25bn). The fall of RJR Nabisco. Yes! Barbarians are really at the gate.

Authors: Qitong Sun and Massimiliano Marchisio Date 30 November 1988 Type of transaction Leveraged Buyout Valuation 7.5-8.0x FY 1988 EBITDA of c. $3.1bn Bidder KKR Target company (sector) Financials RJR Nabisco (Tobacco & Food) FY1988 Rev./EBITDA $16.9bn/$3.1bn (margin c.18.3%) Rationale RJR Nabisco’s operations exhibited moderate and consistent growth, required little capital investment and carried lowContinue reading “ALL TIME CLASSIC! KKR’s first leveraged buyout battle ($25bn). The fall of RJR Nabisco. Yes! Barbarians are really at the gate.”

Alternative investments will hit record $14 trillion AUM in 2023. What about PE?

Alternative investments will hit record $14 trillion AUM in 2023. What about PE? The popularity of the alternative investments space does not come as a novelty in a period in which investors increasingly seek to shy away from the less attractive returns of traditional asset classes. The news is however, that forecasts see the industryContinue reading “Alternative investments will hit record $14 trillion AUM in 2023. What about PE?”

Consolidation in the luxury industry: acquisition of Versace by Michael Kors

Authors: Alessandro Babbaro, Riccardo Lizzi Michael Kors Holdings Limited announced the acquisition of Versace for $2.12bn, on September 25th. Upon completion of the deal, which is expected to be during Q4 2019, the group will rebrand as Capri Holdings with combined annual revenues of $6bn. This deal follows the £896m acquisition of Jimmy Choo, datedContinue reading “Consolidation in the luxury industry: acquisition of Versace by Michael Kors”

Second act! Cinven & Bain launched their final tender offer on the remaining listed shares of Stada, a leading German-based drugmaker, finally valuing the business at over €6bn

By Ricardo Mühle, Felix Paul Schäfer and Massimiliano Marchisio Date October 1st 2018 Type of transaction Public delisting tender offer Valuation 15-15.5x LTM 2018 June EBITDA of c. €410m Bidder Cinven-Bain Capital consortium Target company (sector) Financials STADA AG, “STADA” (Medical – Pharmaceuticals) FY17 Rev. / EBITDA: €2.3bn / €0.4bn (17.4% margin) Advisors (first bid)Continue reading “Second act! Cinven & Bain launched their final tender offer on the remaining listed shares of Stada, a leading German-based drugmaker, finally valuing the business at over €6bn”

Our view on 2019

What’s up buddy? At the beginning of 2018, the VIX, an instrument which tracks the volatility of the S&P500, surged dramatically showing a comeback of fear among investors (Figure 1) following a period of extreme calm started after the financial crisis. Figure 1: Higher VIX since February 2018 Source: Bloomberg February’s spike in volatility ledContinue reading “Our view on 2019”

The Retaliation of Tech

Long we have been used to tech stocks trading at price multiples (price/earnings) at more than the industry standard has been comfortable with for decades. Benjamin Graham’s ideal PE is between 10 and 15 dollars. The Dow Industrial is trading at 25 PE, the S&P 500 is trading at 25 PE. If you thought thatContinue reading “The Retaliation of Tech”